Where does Starpharma Pty Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Starpharma Pty Ltd. ranks #25,283 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Starpharma Pty Ltd. hold?

Starpharma Pty Ltd. holds 11 US utility patents granted between 2015 and 2024, spanning 7 technology areas.

What is Starpharma Pty Ltd.'s Innovation Score?

Starpharma Pty Ltd. has an Innovation Score of 36.9 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Starpharma Pty Ltd.'s patent grant rate increasing or decreasing?

Starpharma Pty Ltd.'s recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Starpharma Pty Ltd.'s patents?

Starpharma Pty Ltd.'s patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Starpharma Pty Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Starpharma Pty Ltd.

Q: What technology areas does Starpharma Pty Ltd. focus on?

Starpharma Pty Ltd.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 10 patents. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Starpharma ranks #25,283 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 7 technology areas.

#25,283
of 50,000 US assignees by volume: Top 45%
by Innovation Score (36.9/100): 20.6
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25283 · Foreign Corporation #25,283 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #25,283/50,000
PHOTO-FINISH Standard BioTools Ca…
CPC-NARROW A61K · 7 areas
INNOV-THIN 36.9/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Standard Biotools Canada Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Starpharma Pty · this assignee

37
3D Lighting Innovati… · lowest

7

What this shows Starpharma's Innovation Score is 36.9/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Starpharma's grants concentrate

Starpharma Pty Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 90.9% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2018. By volume, Starpharma sits between Standard Biotools Canada Inc. and Stion Corporation.

Starpharma's three-year grant acceleration

Starpharma Pty Ltd. shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Standard Biotools…

11
Standard Energy

11
Stanley Works (Eu…

11
Starbuzz® Tobacco

11
State Grid Chongq…

11
Stellar Industries

11
Sterno Products

11
Stion

11
Starpharma Pty ◀

11

What this shows Starpharma holds 11 patents at rank #25,296, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Starpharma

By rank, the assignees closest to #25,296 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Starpharma's primary technology class.

Starpharma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Starpharma Pty Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2017	2	18.2%
2018	1	9.1%
2019	1	9.1%
2020	1	9.1%
2021	1	9.1%
2022	1	9.1%
2024	2	18.2%

Which technologies does Starpharma Pty Ltd. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 10

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 7

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 3

C07D - HETEROCYCLIC COMPOUNDS 2

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#25,283

of 50,000 tracked assignees

Innovation Score

36.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.